Omega-3 fatty acids in the maintenance of ulcerative colitis

Cinzia Papadia; Alessandro Coruzzi; Chiara Montana; Francesco Di Mario; Angelo Franzè; Alastair Forbes

doi:10.1258/shorts.2010.010004

Omega-3 fatty acids in the maintenance of ulcerative colitis

Cinzia Papadia, Alessandro Coruzzi, Chiara Montana, Francesco Di Mario, Angelo Franzè, Alastair Forbes

Research output: Contribution to journal › Article › peer-review

Abstract

Immunomodulation of the gut associated lynphoid tissue is a key issue in the clinical management of inflammatory bowel disease (IBD). Often toxic drugs are used to obtain clinical remission, sometimes in already immunocompromized patients. The presence of important co-morbidity might also heavily affect the clinical strategy. Polyunsaturated fatty acids (PUFAs) might represent a valid therapeutical option in IBD patients and further controlled clinical studies are warranted.

Original language	English
Article number	15
Journal	JRSM Open
Volume	1
Issue number	1
DOIs	https://doi.org/10.1258/shorts.2010.010004
Publication status	Published - 1 Jun 2010

Access to Document

10.1258/shorts.2010.010004

Cite this

@article{06c186b54d494105b923d3025132b0b4,

title = "Omega-3 fatty acids in the maintenance of ulcerative colitis",

abstract = "Immunomodulation of the gut associated lynphoid tissue is a key issue in the clinical management of inflammatory bowel disease (IBD). Often toxic drugs are used to obtain clinical remission, sometimes in already immunocompromized patients. The presence of important co-morbidity might also heavily affect the clinical strategy. Polyunsaturated fatty acids (PUFAs) might represent a valid therapeutical option in IBD patients and further controlled clinical studies are warranted.",

author = "Cinzia Papadia and Alessandro Coruzzi and Chiara Montana and {Di Mario}, Francesco and Angelo Franz{\`e} and Alastair Forbes",

note = "This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. ",

year = "2010",

month = jun,

day = "1",

doi = "10.1258/shorts.2010.010004",

language = "English",

volume = "1",

journal = "JRSM Open",

issn = "2054-2704",

publisher = "Sage Publications",

number = "1",

}

TY - JOUR

T1 - Omega-3 fatty acids in the maintenance of ulcerative colitis

AU - Papadia, Cinzia

AU - Coruzzi, Alessandro

AU - Montana, Chiara

AU - Di Mario, Francesco

AU - Franzè, Angelo

AU - Forbes, Alastair

N1 - This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Immunomodulation of the gut associated lynphoid tissue is a key issue in the clinical management of inflammatory bowel disease (IBD). Often toxic drugs are used to obtain clinical remission, sometimes in already immunocompromized patients. The presence of important co-morbidity might also heavily affect the clinical strategy. Polyunsaturated fatty acids (PUFAs) might represent a valid therapeutical option in IBD patients and further controlled clinical studies are warranted.

AB - Immunomodulation of the gut associated lynphoid tissue is a key issue in the clinical management of inflammatory bowel disease (IBD). Often toxic drugs are used to obtain clinical remission, sometimes in already immunocompromized patients. The presence of important co-morbidity might also heavily affect the clinical strategy. Polyunsaturated fatty acids (PUFAs) might represent a valid therapeutical option in IBD patients and further controlled clinical studies are warranted.

U2 - 10.1258/shorts.2010.010004

DO - 10.1258/shorts.2010.010004

M3 - Article

C2 - 21103107

SN - 2054-2704

VL - 1

JO - JRSM Open

JF - JRSM Open

IS - 1

M1 - 15

ER -